Rare diseases
Investigational molecules
Locations
Back to Czechia191 clinical trials in Hradec Kralove, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
CzechiaStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
CzechiaStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
CzechiaStudy of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes
CzechiaStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
CzechiaStudy on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy
CzechiaStudy on Guselkumab for Healing in Crohn's Disease Patients
CzechiaStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
CzechiaStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including studies evaluating new therapies for both ulcerative colitis and Crohn's disease. Clinical trials are investigating advanced treatments like OD-07656 and TAK-279 for managing moderate to severe cases.
Additional research explores antibiotic optimization and novel therapeutic combinations.
Comprehensive studies in cancer treatment, including trials for metastatic prostate cancer and advanced gastric cancers. Research focuses on innovative therapies combining targeted treatments with immunotherapy approaches.
Investigations include novel drug combinations and immunotherapy strategies.
Advanced research in multiple sclerosis and Parkinson's disease, evaluating new therapeutic approaches and comparing treatment efficacies. Studies include assessments of innovative medications and comparative analyses.
Focus on both disease-modifying treatments and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
